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Discussion
Dr Erik W. Jansen (Utrecht, Netherlands). This is an inter-
esting multicenter trial on an innovative coronary artery, actually
a general vascular, anastomosis technique. On average, 11.8 self-
closing clips were used to create the LITA-to-LAD anastomosis,
requiring a mean anastomosis time of 10 minutes and a minimum
of 3 minutes. Most were done on OPCAB. So this is really a
smooth procedure. That is very good. There were only two con-
versions, no reoperations for bleeding. What was the rate of extra
sutures or clips for hemostasis?
The quality of the anastomosis is well studied by use of the
current standards of FitzGibbon, TIMI, and POEM in angiography
in 77% of patients. The 6-month patency rate as a standard is good,
94% FitzGibbon grade A, and a favorable percent diameter steno-
sis. This compares with the patency in all recent off-pump trials.
There is little intravascular nitinol, thus low thrombogenicity.
Did the patients receive any antithrombotic medication?
The technique looks very attractive and simple. Basically, it is
a classic interrupted technique creating a wide patency, as you
showed. Clear advantages are demonstrated. This is an anastomo-
sis technique based on the surgeon’s skill that is highly compliant
to vessel structure and presentation, and an interrupted suturing
technique that is highly compliant to local calcification and a
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bifurcation. This device is also probably to port-access applica-
tions.
In this study, the bigger ITA and LAD were used, and I assume
mainly in Americans. Is there a limitation in the smaller vessels in
other populations, with small vessels being 1.25 mm? I saw there
were small patients with a mean BMI of 19.7, so this is already a
small index. For the diamond LITA anastomosis, 8.0 sutures are
required.
Should this technique be considered as a clear intermediate
anastomosis technique to the one-shot stapler or as a step up to an
automated one-shot stapler in the future?
Dr Wolf. The first question was what was the rate of extra
sutures or clips for hemostasis? There were no sutures used in this
study, and the average number of clips was the total number of
clips used. So if eight clips were used and then there was a
bleeding point and an additional clip was used, then that patient
had nine clips applied.
The second question was, did the patients receive any anti-
thrombotic medication after operation? That was not part of the
protocol. It was up to the surgeon. Most of these patients received
aspirin after their operation. But, specifically, there was no need
for any other medication.
The third question was, is there a limitation for smaller vessels?
There was a change in my practice on the basis of this study. At
Ohio State University now, all the fellows are taught this tech-
nique, and they like it. This technique is used for all LITA-to-LAD
anastomoses, and, if we have a difficult anastomosis, a small-
caliber artery or a calcified vessel, we tend to use the clips. With
the clips you get a fresh needle for every bite, which causes less
damage to the intima. So I prefer these clips for the smaller
arteries. And now the company has come out with a smaller clip
that is called a “15 clip,” and it is equivalent to a 9-0 suture. So I
believe that facilitates anastomosis in small vessels.
The last question was, is this an intermediate step to a one-shot?
What this really does is signal the emergence of devices in distal
coronary anastomosis, and this probably is the beginning, but it is
a pretty good start. The company has used this device now in more
than 35,000 anastomoses clinically.
Dr G. Hossein Almassi (Milwaukee, Wis). It appears that
although it is an interrupted anastomosis, in terms of the time taken
to do the anastomosis, it was quick similar to a running anasto-
mosis, about 10 minutes. In this day and age we have to keep in
mind how this technology compares with a running suture Prolene
as far as the cost is concerned, and are we gaining something
there?
Dr Wolf. First of all, if you assume that you are going to
perform an interrupted anastomosis and you are going to use 12
sutures or clips, the cost of 12 interrupted silk sutures is $84, 12
interrupted Prolene 7-0 sutures is $120 to $360, depending on the
hospital contract; 8-0, of course, would be much more expensive.
The U-Clip for 12 sutures is $180. If you compare to just a running
suture, then it is going to be one Prolene, which would be,
depending on the hospital contract, much less expensive, probably
$30, something like that.
Dr F. W. Mohr (Leipzig, Germany). How about the nitinol
itself interfering with the anastomosis in terms of visibility in the
angiogram; is there any problem? Is there any hidden area?
Dr Wolf. The nitinol is just barely seen on the angiography. If
one looks very closely, one can discern the clips, but it does not
interfere with the dye study.
Appendix. Exclusion criteria
Preoperative exclusion criteria
Severe cerebrovascular disease, including history of stroke
within 1 month
History of renal insufficiency (serum creatinine level 2 mg/
dL)
Active gastrointestinal bleeding
Active infection or fever (38.3°C), which may be caused by
infection
Short life expectancy (2 years) as a result of cancer or
pulmonary, hepatic, or renal disease
Significant anemia (hemoglobin level 8.0 g)
Severe, uncontrolled systemic hypertension (systolic pressure
240 mm Hg within 1 month)
Severe electrolyte imbalance
Documented anaphylaxis during previous exposure to
angiographic contrast media
Congestive heart failure
Severe systemic disease
History of pericarditis, median sternotomy, or chest irradiation
Uncontrollable diabetes (2 glucose levels 350 mg/dL
within 7 days)
Bleeding diathesis
Vasculitis
History of intravenous drug use within prior year
Participating in another investigational protocol
Unwilling or unable to comply with any protocol requirements
Intraoperative exclusion criteria
Inadequate estimated LITA flow
Small LAD size at anastomotic site (1 mm)
Inadequate or damaged LITA
Severe intramyocardial LAD (off-pump cases)
Other presenting complications prohibiting use of either LITA
or LAD
Unexpected findings of any intraoperative exclusion
Unexpected findings creating an unreasonable intraoperative
risk or an increased probability of postoperative
complications
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